(NASDAQ:ARGX – Free Report) had its price target increased by Guggenheim from $775.00 to $1,100.00 in a report released on Monday morning,Benzinga reports. They currently have a buy rating on the ...

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” fourth quarter 2024 investor letter ...

KORU Medical Systems (NASDAQ:KRMD – Get Free Report) is expected to issue its quarterly earnings data after the market closes on Wednesday, March 12th. Analysts expect the company to announce earnings ...

NHS patients are now receiving lifesaving medicine made from the blood plasma of Berkshire donors. This marks the first time in 25 years that plasma is being used to create medicines for NHS patients, ...

Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profile of VYVGART and VYVGART HytrulogMG patients on VYVGART achieve rapid, substantial, and sustained efficacy ...

A patient from Reading who needed lifesaving treatment developed from blood plasma has thanked donors. Over the past three years, thousands of litres of blood from donors across England has been ...

The global Therapeutic Plasma Exchange Market, valued at US$ 1.5 billion in 2022, is projected to grow at a compound annual ...

A former musician with an autoimmune disease has welcomed the news that lifesaving medicines are now being made from Worcestershire donors.

The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.A recent comprehensive analysis of the Chronic ...

Senators Thom Tillis (R-NC) and Mark Kelly (D-AZ) introduced the bipartisan Preserving Life-saving Access to Specialty ...

Argenx had cash, cash equivalents, and other short-term investments totaling $3.4 billion as of the end of 2024, making it well-positioned to continue funding its pipeline and commercialization ...